Søgeresultater - Axelle Boudrant
- Showing 1 - 2 results of 2
-
1
FOLFIRINOX-3 plus bevacizumab (bFOLFIRINOX3) in chemo-refractory metastatic colorectal cancer: a multicenter phase II trial af Hélène Bellio, Nicolas Roussot, Aurélie Bertaut, Alice Hervieu, Sylvie Zanetta, Zoé Tharin, Julie Vincent, Leila Bengrine, Audrey Hennequin, Jean-Florian Guion, Axelle Boudrant, Thomas Collot, François Ghiringhelli, Jean-David Fumet
Udgivet 2025Artigo -
2
The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families? af Marie Eliade, J. Skrzypski, Amandine Baurand, Caroline Jacquot, Geoffrey Bertolone, Catherine Loustalot, Charles Coutant, France Guy, P. Fumoleau, Yannis Duffourd, Laurent Arnould, Alexandra Delignette, Marie‐Martine Padeano, Côme Lepage, Géraldine Raichon-Patru, Axelle Boudrant, M.C. Böne-Lépinoy, Anne-Laure Villing, Aurélie Charpin, Karine Peignaux, Sandy Chevrier, Frédérique Végran, François Ghiringhelli, Romain Boidot, Nicolas Sévenet, Sarab Lizard, Laurence Faivre
Udgivet 2016Artigo
Søgeredskaber:
Relaterede emner
Cancer
Internal medicine
Medicine
Oncology
Astrobiology
Bevacizumab
Bioinformatics
Biology
Breast cancer
CHEK2
Chemotherapy
Clinical trial
Colorectal cancer
Family history
Gene
Genetic testing
Genetics
Germline mutation
Mutation
Ovarian cancer
Oxaliplatin
PALB2
Penetrance
Phases of clinical research
Phenotype
Physics
Refractory (planetary science)